GLIMITERIS TRIO 0.2 is a potent combination medication used in the management of type 2 diabetes. It comprises Voglibose (0.2 mg), Glimepiride (3 mg), and Metformin Hydrochloride (500 mg). This combination helps in controlling blood sugar levels and reducing the risk of diabetes-related complications.

How Does It Work?

• Voglibose: Inhibits alpha-glucosidase enzymes, delaying carbohydrate absorption in the intestines.
• Glimepiride: Stimulates pancreatic beta cells to release more insulin.
• Metformin Hydrochloride: Decreases hepatic glucose production and increases insulin sensitivity.

Uses of GLIMITERIS TRIO 0.2

• Manages blood sugar levels in type 2 diabetes patients.
• Reduces the risk of cardiovascular diseases associated with diabetes.
• Improves glycemic control when diet and exercise are insufficient.

What is GLIMITERIS TRIO 0.2?

GLIMITERIS TRIO 0.2 is an oral anti-diabetic medication combining three active ingredients:

• Voglibose: An alpha-glucosidase inhibitor.
• Glimepiride: A sulfonylurea.
• Metformin Hydrochloride: A biguanide.

Side Effects

• Common: Nausea, diarrhea, abdominal pain, and hypoglycemia.
• Severe: Lactic acidosis, severe hypoglycemia, and allergic reactions.

Safety Information

• Monitor blood sugar levels regularly.
• Do not skip meals while on this medication.
• Avoid alcohol to reduce the risk of lactic acidosis.
• Inform your doctor about any other medications or supplements you are taking.

If You Need More Information About  GLIMITERIS TRIO 0.2  Click here